SE0103423D0 - Polymorphism - Google Patents
PolymorphismInfo
- Publication number
- SE0103423D0 SE0103423D0 SE0103423A SE0103423A SE0103423D0 SE 0103423 D0 SE0103423 D0 SE 0103423D0 SE 0103423 A SE0103423 A SE 0103423A SE 0103423 A SE0103423 A SE 0103423A SE 0103423 D0 SE0103423 D0 SE 0103423D0
- Authority
- SE
- Sweden
- Prior art keywords
- multiple sclerosis
- lag3
- polymorphism
- predisposition
- seq
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0103423A SE0103423D0 (sv) | 2001-10-12 | 2001-10-12 | Polymorphism |
| PCT/SE2002/001859 WO2003031655A1 (en) | 2001-10-12 | 2002-10-11 | Method for diagnosis of multiple sclerosis by genetic analysis of the lag3 gene |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0103423A SE0103423D0 (sv) | 2001-10-12 | 2001-10-12 | Polymorphism |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE0103423D0 true SE0103423D0 (sv) | 2001-10-12 |
Family
ID=20285649
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE0103423A SE0103423D0 (sv) | 2001-10-12 | 2001-10-12 | Polymorphism |
Country Status (2)
| Country | Link |
|---|---|
| SE (1) | SE0103423D0 (sv) |
| WO (1) | WO2003031655A1 (sv) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1826277A1 (en) | 2006-02-27 | 2007-08-29 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Methods for predicting the response of multiple sclerosis patients to interferon therapy and diagnosing multiple sclerosis |
| EP2380992A1 (en) | 2010-04-21 | 2011-10-26 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Methods for predicting an antibody response to interfer on therapy in multiple sclerosis patients |
| JO3663B1 (ar) | 2014-08-19 | 2020-08-27 | Merck Sharp & Dohme | الأجسام المضادة لمضاد lag3 وأجزاء ربط الأنتيجين |
| BR112018012352A2 (pt) | 2015-12-16 | 2018-12-11 | Merck Sharp & Dohme Corp. | anticorpos anti-lag3 e fragmentos de ligação ao antígeno |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2656800B1 (fr) * | 1990-01-08 | 1992-05-15 | Roussy Inst Gustave | Nouvelles proteines produits par les lymphocytes humains, sequence d'adn codant pour ces proteines et applications pharmaceutiques et biologiques. |
| EP0900841A1 (en) * | 1997-06-18 | 1999-03-10 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | LAG-3 splice variants |
-
2001
- 2001-10-12 SE SE0103423A patent/SE0103423D0/sv unknown
-
2002
- 2002-10-11 WO PCT/SE2002/001859 patent/WO2003031655A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003031655A1 (en) | 2003-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69535802D1 (de) | Genetische veränderungen, die mit lungencarzinomen korrelieren | |
| SG134283A1 (en) | Biomarkers for liver fibrotic injury | |
| EP2003214A3 (en) | Reagents, methods, and libraries for bead-based sequencing | |
| CY1108716T1 (el) | Μεθοδος διαγνωσεως της νοσου του alzheimer με βαση μια μορφη μεταγραφης γονιδιου. | |
| DK0935674T3 (da) | Fremgangsmåde til positionering af kloner ved hjælp af molekylær trimning | |
| WO2003027309A3 (en) | Diagnostic probe detection system | |
| EA199700355A1 (ru) | Метод диагностики шизофрении | |
| DE69531309D1 (de) | Entwurf diskontinuierlicher sonden unter verwendung von hybritopemapping | |
| IL145607A0 (en) | Diagnostic sequencing by a combination of specific cleavage and mass spectrometry | |
| DE60030145D1 (de) | Nachweisverfahren für kurze sequenzvarianten | |
| DE60043944D1 (de) | Zytokin zcyt018 | |
| ATE485391T1 (de) | Zusammensetzungen, methoden und testssysteme zur bestimmung der präsenz von cryptosporidium organismen in einer testprobe | |
| SE0103423D0 (sv) | Polymorphism | |
| DE602006012995D1 (de) | Brustkrebsdiagnoseverfahren | |
| WO2003014879A3 (en) | System and method for identifying a genetic risk factor for a disease or pathology | |
| ATE440968T1 (de) | Verfahren zur diagnostizierung von aspirinunverträglichkeit | |
| WO2002046468A3 (en) | Method for maldi-tof-ms analysis and/or sequencing of oligonucleotides | |
| EP1580265A4 (en) | FROM A NEUROBLASTOM IN STAGE 4S ISOLATED LUCES | |
| FI990380A7 (sv) | Diagnostiskt och sållningsförfarande | |
| WO2003048770A3 (fr) | Procede pour effectuer un diagnostic in vitro au moyen de mecanismes de regulation genetique et trousse de diagnostic correspondante | |
| ATE459646T1 (de) | Diagnoseverfahren für krebs, das durch den nachweis der deletion des g-csf-exons 3 gekennzeichnet ist | |
| ATE414905T1 (de) | Diabetesmodell | |
| WO2007050735A8 (en) | Markers for production traits | |
| WO2005030992A3 (fr) | Procede pour le diagnostic/pronostic du neuroblastome | |
| WO2007039232A3 (en) | Means and methods for diagnosing atgl related disorders |